Advertisement
New Zealand markets open in 9 hours 14 minutes
  • NZX 50

    11,804.84
    -111.94 (-0.94%)
     
  • NZD/USD

    0.5891
    -0.0015 (-0.25%)
     
  • ALL ORDS

    7,862.30
    -147.10 (-1.84%)
     
  • OIL

    85.09
    -0.32 (-0.37%)
     
  • GOLD

    2,390.90
    +7.90 (+0.33%)
     

A Look at the Financial Performance of Spark Therapeutics

A Look at the Financial Performance of Spark Therapeutics

Spark Therapeutics (ONCE) generated revenue of $12 million in 2017 compared to $20.1 million in 2016. Under this collaboration, Spark Therapeutics maintains the responsibility for developing SPK-FIX candidates through Phase 1 and 2 trials. In November 2017, this agreement was amended, and Spark received a $10 million up-front payment and was eligible to receive an additional $15 million.